The Food and Drug Administration has approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections.
The Food and Drug Administration has approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.
Mylan has announced the U.S. launch of its Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day (twice weekly), which is the generic version of Novartis' Vivelle-DOT.
AB Acquisition LLC (Albertsons) and Safeway have entered into agreements to sell 168 stores across eight states to four buyers — Associated Food Stores, Associated Wholesale Grocers, Supervalu and Haggen.
Walgreens on Friday announced that it intends to apply to list the shares of Walgreens Boots Alliance common stock on The Nasdaq Stock Market under the ticker symbol “WBA” following the closing of the previously announced reorganization of Walgreens into a holding company structure.
How is CVS Health planning to replace the loss of $2 billion in tobacco sales? By driving core front-end businesses and improving the shopping experience. In fact, CVS/pharmacy has big plans for health and beauty, Helena Foulkes, EVP and president of CVS/pharmacy, told analysts during the company’s Annual Analyst Day on Dec. 16.
Dollar General on Friday stated that it remains actively engaged in discussions with the Federal Trade Commission regarding the extent of potential divestitures that would be required in connection with an acquisition of Family Dollar Stores.